ACET
Adicet Bio, Inc.Company with tickers: ACET
CIK
1720580
CUSIP
007002207
Shares Outstanding
9,348,236
13F Activity (30d)
44 filings
44 filers
Price
$8.33
Market Cap
$77.87M
P/E Ratio
-0.49
EPS (Diluted)
$-16.95
52W High
$17.44
52W Low
$6.01
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 250,000 |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 250,000 |
| 2026-04-08 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 32,523 |
| 2026-04-08 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 40,416 |
| 2026-04-07 | ORBIMED ADVISORS LLC | 10% Owner | Other | 280,640 |
| 2026-04-07 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 2,400 |
| 2026-04-07 | ORBIMED ADVISORS LLC | 10% Owner | Other | 78,499 |
| 2026-04-07 | ORBIMED ADVISORS LLC | 10% Owner | Other | 564,147 |
| 2026-04-07 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 29,319 |
| 2026-03-25 | Maltzman Julia D. | Chief Medical Officer | Award | 72,555 |
| 2026-03-25 | Healey Don | Chief Technology Officer | Award | 43,361 |
| 2026-03-25 | Schor Chen | Director, President & CEO | Award | 468,555 |
| 2026-03-25 | Harvey Brian Nicholas | Chief Financial Officer | Award | 43,361 |
| 2026-03-25 | Aftab Blake | Chief Scientific Officer | Award | 72,555 |
| 2026-02-20 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 74,751 |
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 74,268 |
| 2026-02-18 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 74,577 |
| 2026-02-17 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 959,028 |
| 2026-02-17 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 0 |
| 2026-01-24 | Schor Chen | Director, President & CEO | Other | 2,716 |
| 2026-01-24 | Schor Chen | Director, President & CEO | Other | 3,339 |
| 2026-01-24 | Schor Chen | Director, President & CEO | Tax | 1,755 |
| 2026-01-24 | Harvey Brian Nicholas | Chief Financial Officer | Tax | 546 |
| 2026-01-24 | Healey Don | Chief Technology Officer | Tax | 535 |
| 2026-01-24 | Aftab Blake | Chief Scientific Officer | Tax | 535 |
| 2025-10-08 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 1,500,000 |
| 2025-10-08 | ORBIMED ADVISORS LLC | 10% Owner | Other | 646,657 |
| 2025-10-08 | ORBIMED ADVISORS LLC | 10% Owner | Buy | 3,500,000 |
| 2025-10-08 | ORBIMED ADVISORS LLC | 10% Owner | Other | 1,027,885 |
| 2025-10-08 | ORBIMED ADVISORS LLC | 10% Owner | Other | 1,255,985 |
| 2025-06-11 | Peng Katie | Director | Award | 26,400 |
| 2025-06-11 | Peng Katie | Director | Award | 5,900 |
| 2025-06-11 | Sinclair Andrew | Director | Award | 5,900 |
| 2025-06-11 | Sinclair Andrew | Director | Award | 26,400 |
| 2025-06-11 | Chodakewitz Jeffrey | Director | Award | 26,400 |
| 2025-06-11 | Chodakewitz Jeffrey | Director | Award | 5,900 |
| 2025-06-11 | DUBIN STEVE | Director | Award | 5,900 |
| 2025-06-11 | DUBIN STEVE | Director | Award | 26,400 |
| 2025-06-11 | Klickstein Lloyd | Director | Award | 5,900 |
| 2025-06-11 | Klickstein Lloyd | Director | Award | 26,400 |
| 2025-04-17 | Grissinger Michael | Director | Award | 70,200 |
| 2025-04-17 | Grissinger Michael | Director | Other | 0 |
| 2025-01-31 | Healey Don | Chief Technology Officer | Award | 275,000 |
| 2025-01-31 | Maltzman Julia D. | Chief Medical Officer | Award | 750,000 |
| 2025-01-31 | Schor Chen | Director, President & CEO | Award | 763,829 |
| 2025-01-31 | Harvey Brian Nicholas | Chief Financial Officer | Award | 324,040 |
| 2025-01-31 | Aftab Blake | Chief Scientific Officer | Award | 275,000 |
| 2025-01-24 | Aftab Blake | Chief Scientific Officer | Tax | 6,270 |
| 2025-01-24 | Harvey Brian Nicholas | Chief Financial Officer | Tax | 8,752 |
| 2025-01-24 | Schor Chen | Director, President & CEO | Other | 43,469 |
| 2025-01-24 | Schor Chen | Director, President & CEO | Other | 53,424 |
| 2025-01-24 | Schor Chen | Director, President & CEO | Tax | 28,101 |
| 2025-01-24 | Healey Don | Chief Technology Officer | Tax | 8,560 |
| 2025-01-13 | Maltzman Julia D. | Chief Medical Officer | Other | 0 |
| 2024-08-21 | Sinclair Andrew | Director | Award | 8,172 |
| 2024-08-21 | Sinclair Andrew | Director | Other | 18,500 |
| 2024-08-21 | Sinclair Andrew | Director | Award | 26,400 |
| 2024-08-21 | Sinclair Andrew | Director | Other | 28,828 |
| 2024-08-21 | Sinclair Andrew | Director | Award | 18,500 |
| 2024-08-21 | Sinclair Andrew | Director | Other | 18,500 |
| 2024-08-21 | Sinclair Andrew | Director | Award | 28,828 |
| 2024-08-21 | Sinclair Andrew | Director | Other | 26,400 |
| 2024-08-21 | Sinclair Andrew | Director | Award | 18,500 |
| 2024-08-21 | Sinclair Andrew | Director | Other | 8,172 |
| 2024-08-21 | GORDON CARL L | Director | Award | 18,500 |
| 2024-08-21 | GORDON CARL L | Director | Award | 18,500 |
| 2024-08-21 | GORDON CARL L | Director | Award | 30,000 |
| 2024-08-21 | GORDON CARL L | Director | Award | 26,400 |
| 2024-08-21 | GORDON CARL L | Director | Other | 18,500 |
| 2024-08-21 | GORDON CARL L | Director | Other | 26,400 |
| 2024-08-21 | GORDON CARL L | Director | Other | 30,000 |
| 2024-08-21 | GORDON CARL L | Director | Other | 18,500 |
| 2024-08-21 | Peng Katie | Director | Award | 70,200 |
| 2024-08-21 | Peng Katie | Director | Other | 70,200 |
| 2024-08-21 | Chodakewitz Jeffrey | Director | Other | 30,000 |
| 2024-08-21 | Chodakewitz Jeffrey | Director | Other | 18,500 |
| 2024-08-21 | Chodakewitz Jeffrey | Director | Award | 18,500 |
| 2024-08-21 | Chodakewitz Jeffrey | Director | Award | 30,000 |
| 2024-08-21 | Chodakewitz Jeffrey | Director | Other | 26,400 |
| 2024-08-21 | Chodakewitz Jeffrey | Director | Other | 18,500 |
| 2024-08-21 | Chodakewitz Jeffrey | Director | Award | 26,400 |
| 2024-08-21 | Chodakewitz Jeffrey | Director | Award | 18,500 |
| 2024-08-21 | Jakobovits Aya | Director | Award | 18,500 |
| 2024-08-21 | Jakobovits Aya | Director | Award | 26,400 |
| 2024-08-21 | Jakobovits Aya | Director | Other | 30,000 |
| 2024-08-21 | Jakobovits Aya | Director | Other | 18,500 |
| 2024-08-21 | Jakobovits Aya | Director | Other | 26,400 |
| 2024-08-21 | Jakobovits Aya | Director | Award | 18,500 |
| 2024-08-21 | Jakobovits Aya | Director | Award | 30,000 |
| 2024-08-21 | DUBIN STEVE | Director | Other | 18,500 |
| 2024-08-21 | DUBIN STEVE | Director | Award | 18,500 |
| 2024-08-21 | DUBIN STEVE | Director | Award | 18,500 |
| 2024-08-21 | DUBIN STEVE | Director | Other | 26,400 |
| 2024-08-21 | DUBIN STEVE | Director | Other | 30,000 |
| 2024-08-21 | DUBIN STEVE | Director | Award | 26,400 |
| 2024-08-21 | DUBIN STEVE | Director | Other | 18,500 |
| 2024-08-21 | DUBIN STEVE | Director | Award | 30,000 |
| 2024-08-21 | Kauffman Michael | Director, President of Development | Other | 26,400 |
| 2024-08-21 | Kauffman Michael | Director, President of Development | Award | 26,400 |
| 2024-08-21 | Kauffman Michael | Director, President of Development | Award | 37,000 |